UBS AM’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
UBS AM's XPH Position: Q3 2026 in Review
UBS AM opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 640 shares worth $41.6K. The stake represents ﹤0.01% of the portfolio and ranks #3455 among its holdings.
117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- UBS AM held 640 shares of State Street SPDR S&P Pharmaceuticals ETF worth $41.6K as of Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF was a new UBS AM position in Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3455 holding.
- 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.